PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,875 Cr | ₹3,851 Cr | ₹4,369 Cr | ₹3,851 Cr | ₹3,118 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹4,875 Cr |
| Mar2025 | ₹3,851 Cr |
| Mar2024 | ₹4,369 Cr |
| Mar2023 | ₹3,851 Cr |
| Mar2022 | ₹3,118 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,875 Cr | 26.60 | |
| Mar2025 | ₹3,851 Cr | -11.87 | |
| Mar2024 | ₹4,369 Cr | 13.46 | |
| Mar2023 | ₹3,851 Cr | 23.51 | |
| Mar2022 | ₹3,118 Cr | - | |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹26,938.9 Cr | -7.2% | -1.2% | 2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -1.5% | 15.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,223.0 Cr | -3% | 8.3% | 52.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹183,453.0 Cr | -2.2% | -1.5% | 35% | Stock Analytics | |
| CIPLA | ₹109,849.0 Cr | -0.6% | -4.9% | -13% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,591.8 Cr | 0.2% | -3.9% | -11.8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -7.2% |
-1.2% |
2.2% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses